Variant · Snv
RAD51C NM_058216.3(RAD51C):c.859A>G (p.Thr287Ala)
CI-VAR-00020555Explore in graph →p.Thr287AlaNM_058216.3:c.859A>GClinVar 132702 rs28363317
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 132702 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Fanconi anemia complementation group O; Hereditary cancer-predisposing syndrome; Breast-ovarian cancer, familial, susceptibility to, 3; Malignant tumor of breast; Hereditary breast ovarian cancer syndrome; Breast and/or ovarian cancer; RAD51C-related disorder | germline | 32 | Jun 01, 2026 | clinvar |